# C_2008146EN.01001301.xml

| 12.6.2008 | EN | Official Journal of the European Union | C 146/13 |
| --- | --- | --- | --- |

12.6.2008

EN

Official Journal of the European Union

C 146/13

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2007

(2008/C 146/03)

Subcommittee I — On the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2007, at their meeting on 14 March 2008:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

List of new marketing authorisations

Annex II

List of renewed marketing authorisations

Annex III

List of extended marketing authorisations

Annex IV

List of withdrawn marketing authorisations

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2007:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/361/001 | Luminity | Liechtenstein | 31.12.2007 |
| EU/1/07/387/001-008 | Advagraf | Liechtenstein | 31.12.2007 |
| EU/1/07/391/001/NO-004/NO | Revlimid | Norway | 13.7.2007 |
| EU/1/07/391/001-004/IS | Revlimid | Iceland | 11.7.2007 |
| EU/1/07/392/001 | Circadin | Liechtenstein | 31.8.2007 |
| EU/1/07/392/001/IS | Circadin | Iceland | 8.8.2007 |
| EU/1/07/392/001/NO | Circadin | Norway | 15.8.2007 |
| EU/1/07/393/001/IS | Soliris | Iceland | 19.7.2007 |
| EU/1/07/393/001/NO | Soliris | Norway | 19.7.2007 |
| EU/1/07/394/001/NO-006/NO | Optaflu | Norway | 20.8.2007 |
| EU/1/07/395/001/NO-064/NO | Invega | Norway | 17.7.2007 |
| EU/1/07/395/001-064 | Invega | Liechtenstein | 31.8.2007 |
| EU/1/07/395/001-064/IS | Invega | Iceland | 20.7.2007 |
| EU/1/07/396/001/NO-003/NO | Pergoveris | Norway | 3.7.2007 |
| EU/1/07/396/001-003 | Pergoveris | Liechtenstein | 31.8.2007 |
| EU/1/07/396/001-003/IS | Pergoveris | Iceland | 20.7.2007 |
| EU/1/07/397/001 | Siklos | Liechtenstein | 31.8.2007 |
| EU/1/07/397/001/IS | Siklos | Iceland | 19.7.2007 |
| EU/1/07/397/001/NO | Siklos | Norway | 22.8.2007 |
| EU/1/07/398/001/NO-014/NO | Optimark | Norway | 20.8.2007 |
| EU/1/07/398/001-014 | OptiMark | Liechtenstein | 31.8.2007 |
| EU/1/07/398/001-014/IS | OptiMark | Iceland | 20.8.2007 |
| EU/1/07/399/001/NO-006/NO | Aerinaze | Norway | 22.8.2007 |
| EU/1/07/399/001-006 | Aerinaze | Liechtenstein | 31.8.2007 |
| EU/1/07/399/001-006/IS | Aerinaze | Iceland | 30.8.2007 |
| EU/1/07/400/001/NO-016/NO | Mircera | Norway | 3.9.2007 |
| EU/1/07/400/001-016/IS | Mircera | Iceland | 17.8.2007 |
| EU/1/07/401/001/NO-006/NO | Orlistat GSK | Norway | 20.8.2007 |
| EU/1/07/401/001-006 | Orlistat GSK | Liechtenstein | 31.8.2007 |
| EU/1/07/401/001-006/IS | Orlistat GSK | Iceland | 21.8.2007 |
| EU/1/07/402/001 | Increlex | Liechtenstein | 31.8.2007 |
| EU/1/07/402/001/IS | Increlex | Iceland | 31.8.2007 |
| EU/1/07/403/001 | Atriance | Liechtenstein | 31.10.2007 |
| EU/1/07/403/001/IS | Atriance | Iceland | 20.9.2007 |
| EU/1/07/403/001/NO | Atriance | Norway | 4.9.2007 |
| EU/1/07/404/001/NO-005/NO | Flebogammadif | Norway | 13.9.2007 |
| EU/1/07/404/001-005 | Flebogammadif | Liechtenstein | 31.10.2007 |
| EU/1/07/404/001-005/IS | Flebogammadif | Iceland | 13.9.2007 |
| EU/1/07/405/001/NO-020/NO | Rasilez | Norway | 14.9.2007 |
| EU/1/07/405/001-020 | Rasilez | Liechtenstein | 31.10.2007 |
| EU/1/07/405/001-020/IS | Rasilez | Iceland | 6.9.2007 |
| EU/1/07/406/001/NO-020/NO | Enviage | Norway | 14.9.2007 |
| EU/1/07/406/001-020 | Enviage | Liechtenstein | 31.10.2007 |
| EU/1/07/406/001-020/IS | Enviage | Iceland | 11.9.2007 |
| EU/1/07/407/001/NO-020/NO | Sprimeo | Norway | 14.9.2007 |
| EU/1/07/407/001-020 | Sprimeo | Liechtenstein | 31.10.2007 |
| EU/1/07/407/001-020/IS | Sprimeo | Iceland | 11.9.2007 |
| EU/1/07/408/001/NO-020/NO | Tekturna | Norway | 14.9.2007 |
| EU/1/07/408/001-020 | Tekturna | Liechtenstein | 31.10.2007 |
| EU/1/07/408/001-020/IS | Tekturna | Iceland | 6.9.2007 |
| EU/1/07/409/001/NO-020/NO | Riprazo | Norway | 14.9.2007 |
| EU/1/07/409/001-020 | Riprazo | Liechtenstein | 31.10.2007 |
| EU/1/07/409/001-020/IS | Riprazo | Iceland | 11.9.2007 |
| EU/1/07/410/001/NO-016/NO | Binocrit | Norway | 13.9.2007 |
| EU/1/07/410/001-016 | Binocrit | Liechtenstein | 31.10.2007 |
| EU/1/07/410/001-016/IS | Binocrit | Iceland | 18.9.2007 |
| EU/1/07/411/001/NO-016/NO | Epoetin alfa Hexal | Norway | 13.9.2007 |
| EU/1/07/411/001-016 | Epoetin alfa Hexal | Liechtenstein | 31.10.2007 |
| EU/1/07/411/001-016/IS | Epoetin alfa Hexal | Iceland | 19.9.2007 |
| EU/1/07/412/001/NO-016/NO | Abseamed | Norway | 12.9.2007 |
| EU/1/07/412/001-016 | Abseamed | Liechtenstein | 31.10.2007 |
| EU/1/07/412/001-016/IS | Abseamed | Iceland | 19.9.2007 |
| EU/1/07/413/001/NO-003/NO | Gliolan | Norway | 28.9.2007 |
| EU/1/07/413/001-003 | Gliolan | Liechtenstein | 31.10.2007 |
| EU/1/07/413/001-003/IS | Gliolan | Iceland | 21.9.2007 |
| EU/1/07/414/001/NO-017/NO | Galvus | Norway | 8.10.2007 |
| EU/1/07/414/001-017 | Galvus | Liechtenstein | 31.10.2007 |
| EU/1/07/414/001-017/IS | Galvus | Iceland | 18.10.2007 |
| EU/1/07/415/001/NO-056/NO | Zalasta | Norway | 16.10.2007 |
| EU/1/07/415/001-056/IS | Zalasta | Iceland | 26.10.2007 |
| EU/1/07/415/001-056 | Zalasta | Liechtenstein | 31.10.2007 |
| EU/1/07/416/001 | Ecalta | Liechtenstein | 31.10.2007 |
| EU/1/07/416/001/IS | Ecalta | Iceland | 13.10.2007 |
| EU/1/07/416/001/NO | Ecalta | Norway | 28.9.2007 |
| EU/1/07/417/001/NO-002/NO | Yondelis | Norway | 23.10.2007 |
| EU/1/07/417/001-002 | Yondelis | Liechtenstein | 31.10.2007 |
| EU/1/07/417/001-002/IS | Yondelis | Iceland | 15.10.2007 |
| EU/1/07/418/001/NO-010/NO | Celsentri | Norway | 25.9.2007 |
| EU/1/07/418/001-010 | Celsentri | Liechtenstein | 31.10.2007 |
| EU/1/07/418/001-010/IS | Celsentri | Iceland | 13.10.2007 |
| EU/1/07/419/001/NO-009/NO | Cervarix | Norway | 25.9.2007 |
| EU/1/07/419/001-009 | Cervarix | Liechtenstein | 31.10.2007 |
| EU/1/07/419/001-009/IS | Cervarix | Iceland | 12.10.2007 |
| EU/1/07/420/001 | Cyanokit | Liechtenstein | 31.12.2007 |
| EU/1/07/420/001/IS | Cyanokit | Iceland | 17.12.2007 |
| EU/1/07/420/001/NO | Cyanokit | Norway | 19.12.2007 |
| EU/1/07/421/001/NO-009/NO | Pioglitazon/metformin Takeda | Norway | 19.12.2007 |
| EU/1/07/421/001-009 | Pioglitazone/Metformin Hydrochloride Takeda | Liechtenstein | 31.12.2007 |
| EU/1/07/422/001-004/IS | Tasigna | Iceland | 14.12.2007 |
| EU/1/07/424/001 | Torisel | Liechtenstein | 31.12.2007 |
| EU/1/07/424/001/IS | Torisel | Iceland | 10.12.2007 |
| EU/1/07/424/001/NO | Torisel | Norway | 3.12.2007 |
| EU/1/07/425/001/NO-018/NO | Eucreas | Norway | 5.12.2007 |
| EU/1/07/425/001-018 | Eucreas | Liechtenstein | 31.12.2007 |
| EU/1/07/425/001-018/IS | Eucreas | Iceland | 6.12.2007 |
| EU/1/07/426/001/NO-011/NO | Olanzapine Neopharma | Norway | 19.12.2007 |
| EU/1/07/426/001-011/IS | Olanzapine Neopharma | Iceland | 7.12.2007 |
| EU/1/07/426/001-011 | Olanzapine Neopharma | Liechtenstein | 31.12.2007 |
| EU/1/07/433/001 | Nevanac | Liechtenstein | 31.12.2007 |
| EU/1/07/433/001/NO | Nevanac | Norway | 18.12.2007 |
| EU/107/427/001-037 | Olanzapine Teva | Liechtenstein | 31.12.2007 |
| EU/2/06/067/001-002 | Medicinal Oxygen Air Liquide Santé | Liechtenstein | 31.12.2007 |
| EU/2/06/070/001-003/IS | Meloxidyl | Iceland | 17.8.2007 |
| EU/2/07/072/001/NO-002/NO | Suprelorin | Norway | 24.10.2007 |
| EU/2/07/072/001-002 | Suprelorin | Liechtenstein | 31.8.2007 |
| EU/2/07/072/001-002/IS | Suprelorin | Iceland | 10.8.2007 |
| EU/2/07/074/001/NO-006/NO | Prilactone | Norway | 20.12.2007 |
| EU/2/07/074/001-006/IS | Prilactone | Iceland | 19.7.2007 |
| EU/2/07/075/001/NO-004/NO | Circovac | Norway | 20.12.2007 |
| EU/2/07/075/001-004 | Circovac | Liechtenstein | 31.8.2007 |
| EU/2/07/075/001-004/IS | Circovac | Iceland | 12.7.2007 |
| EU/2/07/077/001-005 | Meloxivet | Liechtenstein | 31.12.2007 |

EU Number

Product

Country

Date of authorisation

EU/1/06/361/001

Luminity

Liechtenstein

31.12.2007

EU/1/07/387/001-008

Advagraf

Liechtenstein

31.12.2007

EU/1/07/391/001/NO-004/NO

Revlimid

Norway

13.7.2007

EU/1/07/391/001-004/IS

Revlimid

Iceland

11.7.2007

EU/1/07/392/001

Circadin

Liechtenstein

31.8.2007

EU/1/07/392/001/IS

Circadin

Iceland

8.8.2007

EU/1/07/392/001/NO

Circadin

Norway

15.8.2007

EU/1/07/393/001/IS

Soliris

Iceland

19.7.2007

EU/1/07/393/001/NO

Soliris

Norway

19.7.2007

EU/1/07/394/001/NO-006/NO

Optaflu

Norway

20.8.2007

EU/1/07/395/001/NO-064/NO

Invega

Norway

17.7.2007

EU/1/07/395/001-064

Invega

Liechtenstein

31.8.2007

EU/1/07/395/001-064/IS

Invega

Iceland

20.7.2007

EU/1/07/396/001/NO-003/NO

Pergoveris

Norway

3.7.2007

EU/1/07/396/001-003

Pergoveris

Liechtenstein

31.8.2007

EU/1/07/396/001-003/IS

Pergoveris

Iceland

20.7.2007

EU/1/07/397/001

Siklos

Liechtenstein

31.8.2007

EU/1/07/397/001/IS

Siklos

Iceland

19.7.2007

EU/1/07/397/001/NO

Siklos

Norway

22.8.2007

EU/1/07/398/001/NO-014/NO

Optimark

Norway

20.8.2007

EU/1/07/398/001-014

OptiMark

Liechtenstein

31.8.2007

EU/1/07/398/001-014/IS

OptiMark

Iceland

20.8.2007

EU/1/07/399/001/NO-006/NO

Aerinaze

Norway

22.8.2007

EU/1/07/399/001-006

Aerinaze

Liechtenstein

31.8.2007

EU/1/07/399/001-006/IS

Aerinaze

Iceland

30.8.2007

EU/1/07/400/001/NO-016/NO

Mircera

Norway

3.9.2007

EU/1/07/400/001-016/IS

Mircera

Iceland

17.8.2007

EU/1/07/401/001/NO-006/NO

Orlistat GSK

Norway

20.8.2007

EU/1/07/401/001-006

Orlistat GSK

Liechtenstein

31.8.2007

EU/1/07/401/001-006/IS

Orlistat GSK

Iceland

21.8.2007

EU/1/07/402/001

Increlex

Liechtenstein

31.8.2007

EU/1/07/402/001/IS

Increlex

Iceland

31.8.2007

EU/1/07/403/001

Atriance

Liechtenstein

31.10.2007

EU/1/07/403/001/IS

Atriance

Iceland

20.9.2007

EU/1/07/403/001/NO

Atriance

Norway

4.9.2007

EU/1/07/404/001/NO-005/NO

Flebogammadif

Norway

13.9.2007

EU/1/07/404/001-005

Flebogammadif

Liechtenstein

31.10.2007

EU/1/07/404/001-005/IS

Flebogammadif

Iceland

13.9.2007

EU/1/07/405/001/NO-020/NO

Rasilez

Norway

14.9.2007

EU/1/07/405/001-020

Rasilez

Liechtenstein

31.10.2007

EU/1/07/405/001-020/IS

Rasilez

Iceland

6.9.2007

EU/1/07/406/001/NO-020/NO

Enviage

Norway

14.9.2007

EU/1/07/406/001-020

Enviage

Liechtenstein

31.10.2007

EU/1/07/406/001-020/IS

Enviage

Iceland

11.9.2007

EU/1/07/407/001/NO-020/NO

Sprimeo

Norway

14.9.2007

EU/1/07/407/001-020

Sprimeo

Liechtenstein

31.10.2007

EU/1/07/407/001-020/IS

Sprimeo

Iceland

11.9.2007

EU/1/07/408/001/NO-020/NO

Tekturna

Norway

14.9.2007

EU/1/07/408/001-020

Tekturna

Liechtenstein

31.10.2007

EU/1/07/408/001-020/IS

Tekturna

Iceland

6.9.2007

EU/1/07/409/001/NO-020/NO

Riprazo

Norway

14.9.2007

EU/1/07/409/001-020

Riprazo

Liechtenstein

31.10.2007

EU/1/07/409/001-020/IS

Riprazo

Iceland

11.9.2007

EU/1/07/410/001/NO-016/NO

Binocrit

Norway

13.9.2007

EU/1/07/410/001-016

Binocrit

Liechtenstein

31.10.2007

EU/1/07/410/001-016/IS

Binocrit

Iceland

18.9.2007

EU/1/07/411/001/NO-016/NO

Epoetin alfa Hexal

Norway

13.9.2007

EU/1/07/411/001-016

Epoetin alfa Hexal

Liechtenstein

31.10.2007

EU/1/07/411/001-016/IS

Epoetin alfa Hexal

Iceland

19.9.2007

EU/1/07/412/001/NO-016/NO

Abseamed

Norway

12.9.2007

EU/1/07/412/001-016

Abseamed

Liechtenstein

31.10.2007

EU/1/07/412/001-016/IS

Abseamed

Iceland

19.9.2007

EU/1/07/413/001/NO-003/NO

Gliolan

Norway

28.9.2007

EU/1/07/413/001-003

Gliolan

Liechtenstein

31.10.2007

EU/1/07/413/001-003/IS

Gliolan

Iceland

21.9.2007

EU/1/07/414/001/NO-017/NO

Galvus

Norway

8.10.2007

EU/1/07/414/001-017

Galvus

Liechtenstein

31.10.2007

EU/1/07/414/001-017/IS

Galvus

Iceland

18.10.2007

EU/1/07/415/001/NO-056/NO

Zalasta

Norway

16.10.2007

EU/1/07/415/001-056/IS

Zalasta

Iceland

26.10.2007

EU/1/07/415/001-056

Zalasta

Liechtenstein

31.10.2007

EU/1/07/416/001

Ecalta

Liechtenstein

31.10.2007

EU/1/07/416/001/IS

Ecalta

Iceland

13.10.2007

EU/1/07/416/001/NO

Ecalta

Norway

28.9.2007

EU/1/07/417/001/NO-002/NO

Yondelis

Norway

23.10.2007

EU/1/07/417/001-002

Yondelis

Liechtenstein

31.10.2007

EU/1/07/417/001-002/IS

Yondelis

Iceland

15.10.2007

EU/1/07/418/001/NO-010/NO

Celsentri

Norway

25.9.2007

EU/1/07/418/001-010

Celsentri

Liechtenstein

31.10.2007

EU/1/07/418/001-010/IS

Celsentri

Iceland

13.10.2007

EU/1/07/419/001/NO-009/NO

Cervarix

Norway

25.9.2007

EU/1/07/419/001-009

Cervarix

Liechtenstein

31.10.2007

EU/1/07/419/001-009/IS

Cervarix

Iceland

12.10.2007

EU/1/07/420/001

Cyanokit

Liechtenstein

31.12.2007

EU/1/07/420/001/IS

Cyanokit

Iceland

17.12.2007

EU/1/07/420/001/NO

Cyanokit

Norway

19.12.2007

EU/1/07/421/001/NO-009/NO

Pioglitazon/metformin Takeda

Norway

19.12.2007

EU/1/07/421/001-009

Pioglitazone/Metformin Hydrochloride Takeda

Liechtenstein

31.12.2007

EU/1/07/422/001-004/IS

Tasigna

Iceland

14.12.2007

EU/1/07/424/001

Torisel

Liechtenstein

31.12.2007

EU/1/07/424/001/IS

Torisel

Iceland

10.12.2007

EU/1/07/424/001/NO

Torisel

Norway

3.12.2007

EU/1/07/425/001/NO-018/NO

Eucreas

Norway

5.12.2007

EU/1/07/425/001-018

Eucreas

Liechtenstein

31.12.2007

EU/1/07/425/001-018/IS

Eucreas

Iceland

6.12.2007

EU/1/07/426/001/NO-011/NO

Olanzapine Neopharma

Norway

19.12.2007

EU/1/07/426/001-011/IS

Olanzapine Neopharma

Iceland

7.12.2007

EU/1/07/426/001-011

Olanzapine Neopharma

Liechtenstein

31.12.2007

EU/1/07/433/001

Nevanac

Liechtenstein

31.12.2007

EU/1/07/433/001/NO

Nevanac

Norway

18.12.2007

EU/107/427/001-037

Olanzapine Teva

Liechtenstein

31.12.2007

EU/2/06/067/001-002

Medicinal Oxygen Air Liquide Santé

Liechtenstein

31.12.2007

EU/2/06/070/001-003/IS

Meloxidyl

Iceland

17.8.2007

EU/2/07/072/001/NO-002/NO

Suprelorin

Norway

24.10.2007

EU/2/07/072/001-002

Suprelorin

Liechtenstein

31.8.2007

EU/2/07/072/001-002/IS

Suprelorin

Iceland

10.8.2007

EU/2/07/074/001/NO-006/NO

Prilactone

Norway

20.12.2007

EU/2/07/074/001-006/IS

Prilactone

Iceland

19.7.2007

EU/2/07/075/001/NO-004/NO

Circovac

Norway

20.12.2007

EU/2/07/075/001-004

Circovac

Liechtenstein

31.8.2007

EU/2/07/075/001-004/IS

Circovac

Iceland

12.7.2007

EU/2/07/077/001-005

Meloxivet

Liechtenstein

31.12.2007

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2007:

| EU Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/02/209/001/NO-008/NO | Dynastat | Norway | 14.9.2007 |
| EU/1/02/216/001/NO-002/NO | Invanz | Norway | 4.7.2007 |
| EU/1/02/218/001/NO-011/NO | Axura | Norway | 16.7.2007 |
| EU/1/02/218/001-011/IS | Axura | Iceland | 11.7.2007 |
| EU/1/02/219/001/NO-015/NO | Ebixa | Norway | 11.7.2007 |
| EU/1/02/219/001-015/IS | Ebixa | Iceland | 6.7.2007 |
| EU/1/02/220/001/NO-005/NO | Tracleer | Norway | 13.8.2007 |
| EU/1/02/221/001/NO-010/NO | Pegasys | Norway | 18.7.2007 |
| EU/1/02/221/001-010/IS | Pegasys | Iceland | 13.7.2007 |
| EU/1/02/221/001-010 | Pegasys | Liechtenstein | 31.8.2007 |
| EU/1/02/222/001/NO-002/NO | Tamiflu | Norway | 31.7.2007 |
| EU/1/02/222/001-002 | Tamiflu | Liechtenstein | 31.8.2007 |
| EU/1/02/222/001-004/IS | Tamiflu | Iceland | 13.7.2007 |
| EU/1/02/223/001/NO-003/NO | Evra | Norway | 17.9.2007 |
| EU/1/02/223/001-003 | Evra | Liechtenstein | 31.10.2007 |
| EU/1/02/223/001-003/IS | Evra | Iceland | 1.10.2007 |
| EU/1/02/224/001/NO-005/NO | Ambirix | Norway | 25.9.2007 |
| EU/1/02/224/001-005 | Ambirix | Liechtenstein | 31.10.2007 |
| EU/1/02/224/001-005/IS | Ambirix | Iceland | 1.10.2007 |
| EU/1/02/225/001/NO-002/NO | Xigris | Norway | 27.8.2007 |
| EU/1/02/225/001-002 | Xigris | Liechtenstein | 31.8.2007 |
| EU/1/02/225/001-002/IS | Xigris | Iceland | 16.8.2007 |
| EU/1/02/226/001 | InductOs | Liechtenstein | 31.10.2007 |
| EU/1/02/226/001/IS | InductOs | Iceland | 17.9.2007 |
| EU/1/02/226/001/NO | InductOs | Norway | 10.9.2007 |
| EU/1/02/227/001/NO-003/NO | Neulasta | Norway | 27.8.2007 |
| EU/1/02/227/001-003 | Neulasta | Liechtenstein | 31.8.2007 |
| EU/1/02/227/001-003/IS | Neulasta | Iceland | 16.8.2007 |
| EU/1/02/228/001-003/IS | Neupopeg | Iceland | 15.8.2007 |
| EU/1/02/228/001/NO-003/NO | Neupopeg | Norway | 27.8.2007 |
| EU/1/02/228/001-003 | Neupopeg | Liechtenstein | 31.8.2007 |
| EU/1/02/229/001/NO-037/NO | Actraphane | Norway | 9.10.2007 |
| EU/1/02/229/001-037 | Actraphane | Liechtenstein | 31.10.2007 |
| EU/1/02/229/001-037/IS | Actraphane | Iceland | 15.10.2007 |
| EU/1/02/230/001/NO-017/NO | Actrapid | Norway | 9.10.2007 |
| EU/1/02/230/001-017 | Actrapid | Liechtenstein | 31.10.2007 |
| EU/1/02/230/001-017/IS | Actrapid | Iceland | 15.10.2007 |
| EU/1/02/231/001/NO-037/NO | Mixtard | Norway | 9.10.2007 |
| EU/1/02/231/001-037 | Mixtard | Liechtenstein | 31.10.2007 |
| EU/1/02/231/001-037/IS | Mixtard | Iceland | 16.10.2007 |
| EU/1/02/232/001/NO-003/NO | Velosulin | Norway | 9.10.2007 |
| EU/1/02/232/001-003 | Velosulin | Liechtenstein | 31.10.2007 |
| EU/1/02/232/001-003/IS | Velosulin | Iceland | 15.10.2007 |
| EU/1/02/233/001/NO-017/NO | Insulatard | Norway | 9.10.2007 |
| EU/1/02/233/001-017 | Insulatard | Liechtenstein | 31.10.2007 |
| EU/1/02/233/001-017/IS | Insulatard | Iceland | 16.10.2007 |
| EU/1/02/234/001/NO-017/NO | Protaphane | Norway | 9.10.2007 |
| EU/1/02/234/001-017 | Protaphane | Liechtenstein | 31.10.2007 |
| EU/1/02/234/001-017/IS | Protaphane | Iceland | 15.10.2007 |
| EU/1/02/237/001/NO-008/NO | Cialis | Norway | 15.10.2007 |
| EU/1/02/237/001-008 | Cialis | Liechtenstein | 31.10.2007 |
| EU/1/02/237/001-008/IS | Cialis | Iceland | 15.10.2007 |
| EU/1/02/238/001 | Zavesca | Liechtenstein | 31.10.2007 |
| EU/1/02/238/001/IS | Zavesca | Iceland | 1.10.2007 |
| EU/1/02/238/001/NO | Zavesca | Norway | 17.9.2007 |
| EU/1/02/240/001/NO-004/NO | Somavert | Norway | 26.9.2007 |
| EU/1/02/240/001-004 | Somavert | Liechtenstein | 31.10.2007 |
| EU/1/02/240/001-004/IS | Somavert | Iceland | 19.10.2007 |
| EU/1/97/031/001/NO-003/NO, 019/NO-046/NO | Neorecormon | Norway | 17.7.2007 |
| EU/1/97/031/001-003, 019-046 | NeoRecormon | Liechtenstein | 31.8.2007 |
| EU/1/97/031/001-013, 019-024, 027-046/IS | NeoRecormon | Iceland | 11.7.2007 |
| EU/1/97/032/001/NO | LeukoScan | Norway | 4.7.2007 |
| EU/1/97/037/001/IS | Vistide | Iceland | 6.7.2007 |
| EU/1/97/037/001/NO | Vistide | Norway | 13.9.2007 |
| EU/1/97/039/001/NO-004/NO | Cystagon | Norway | 31.7.2007 |
| EU/1/97/039/001-004 | Cystagon | Liechtenstein | 31.8.2007 |
| EU/1/97/039/001-004/IS | Cystagon | Iceland | 11.7.2007 |
| EU/1/97/040/001/NO-002/NO | Teslascan | Norway | 20.8.2007 |
| EU/1/97/043/001/NO-003/NO | Revasc | Norway | 16.7.2007 |
| EU/1/97/043/001-003 | Revasc | Liechtenstein | 31.8.2007 |
| EU/1/97/043/001-003/IS | Revasc | Iceland | 11.7.2007 |
| EU/1/97/046/001/NO-039/NO | Aprovel | Norway | 19.9.2007 |
| EU/1/97/046/001-033 | Aprovel | Liechtenstein | 31.10.2007 |
| EU/1/97/046/001-039/IS | Aprovel | Iceland | 18.9.2007 |
| EU/1/97/047/001/NO-007/NO | BeneFIX | Norway | 11.9.2007 |
| EU/1/97/047/001-007 | Benefix | Liechtenstein | 31.10.2007 |
| EU/1/97/047/001-007/IS | BeneFix | Iceland | 31.8.2007 |
| EU/1/97/049/001/NO-039/NO | Karvea | Norway | 20.9.2007 |
| EU/1/97/049/001-033 | Karvea | Liechtenstein | 31.10.2007 |
| EU/1/97/049/001-039/IS | Karvea | Iceland | 17.9.2007 |
| EU/1/97/050/001/NO-006/NO, 009/NO-012/NO | Sifrol | Norway | 16.10.2007 |
| EU/1/97/050/001-006, 009-012 | Sifrol | Liechtenstein | 31.10.2007 |
| EU/1/97/050/001-006, 009-012/IS | Sifrol | Iceland | 15.10.2007 |
| EU/1/97/051/001/NO-006/NO, 009/NO-012/NO | Mirapexin | Norway | 15.10.2007 |
| EU/1/97/051/001-006, 009-012 | Mirapexin | Liechtenstein | 31.10.2007 |
| EU/1/97/051/001-006, 009-012/IS | Mirapexin | Iceland | 15.10.2007 |
| EU/1/97/053/001/NO-005/NO | Cerezyme | Norway | 9.10.2007 |
| EU/1/97/053/001-005 | Cerezyme | Liechtenstein | 31.10.2007 |
| EU/1/97/053/001-005/IS | Cerezyme | Iceland | 15.10.2007 |
| EU/1/97/057/001 | Quadramet | Liechtenstein | 31.12.2007 |
| EU/2/02/032/001/IS | Vaxxitek HVT + IBD | Iceland | 10.7.2007 |
| EU/2/02/033/001/IS | Dexdomitor | Iceland | 17.8.2007 |
| EU/2/02/034/001/IS | Nobivac Bb cat | Iceland | 19.10.2007 |
| EU/2/02/035/001-007 | SevoFlo | Liechtenstein | 31.12.2007 |
| EU/2/02/035/001-007/IS | SevoFlo | Iceland | 6.12.2007 |
| EU/2/033/001 | Dexdomitor | Liechtenstein | 31.10.2007 |
| EU/2/034/001 | Nobivac Bb | Liechtenstein | 31.10.2007 |
| EU/2/97/001-009/IS | Quadrisol | Iceland | 10.12.2007 |
| EU/2/97/004/001, EU/2/97/004/003-028 | Metacam | Liechtenstein | 31.12.2007 |
| EU/2/97/004/001/NO, 003/NO-030/NO | Metacam | Norway | 17.12.2007 |
| EU/2/97/005/001-009 | Quadrisol | Liechtenstein | 31.12.2007 |
| EU/2/98/010/004-014, 017-018, 021-024/IS | Econor | Iceland | 8.11.2007 |

EU Number

Product

Country

Date of authorisation

EU/1/02/209/001/NO-008/NO

Dynastat

Norway

14.9.2007

EU/1/02/216/001/NO-002/NO

Invanz

Norway

4.7.2007

EU/1/02/218/001/NO-011/NO

Axura

Norway

16.7.2007

EU/1/02/218/001-011/IS

Axura

Iceland

11.7.2007

EU/1/02/219/001/NO-015/NO

Ebixa

Norway

11.7.2007

EU/1/02/219/001-015/IS

Ebixa

Iceland

6.7.2007

EU/1/02/220/001/NO-005/NO

Tracleer

Norway

13.8.2007

EU/1/02/221/001/NO-010/NO

Pegasys

Norway

18.7.2007

EU/1/02/221/001-010/IS

Pegasys

Iceland

13.7.2007

EU/1/02/221/001-010

Pegasys

Liechtenstein

31.8.2007

EU/1/02/222/001/NO-002/NO

Tamiflu

Norway

31.7.2007

EU/1/02/222/001-002

Tamiflu

Liechtenstein

31.8.2007

EU/1/02/222/001-004/IS

Tamiflu

Iceland

13.7.2007

EU/1/02/223/001/NO-003/NO

Evra

Norway

17.9.2007

EU/1/02/223/001-003

Evra

Liechtenstein

31.10.2007

EU/1/02/223/001-003/IS

Evra

Iceland

1.10.2007

EU/1/02/224/001/NO-005/NO

Ambirix

Norway

25.9.2007

EU/1/02/224/001-005

Ambirix

Liechtenstein

31.10.2007

EU/1/02/224/001-005/IS

Ambirix

Iceland

1.10.2007

EU/1/02/225/001/NO-002/NO

Xigris

Norway

27.8.2007

EU/1/02/225/001-002

Xigris

Liechtenstein

31.8.2007

EU/1/02/225/001-002/IS

Xigris

Iceland

16.8.2007

EU/1/02/226/001

InductOs

Liechtenstein

31.10.2007

EU/1/02/226/001/IS

InductOs

Iceland

17.9.2007

EU/1/02/226/001/NO

InductOs

Norway

10.9.2007

EU/1/02/227/001/NO-003/NO

Neulasta

Norway

27.8.2007

EU/1/02/227/001-003

Neulasta

Liechtenstein

31.8.2007

EU/1/02/227/001-003/IS

Neulasta

Iceland

16.8.2007

EU/1/02/228/001-003/IS

Neupopeg

Iceland

15.8.2007

EU/1/02/228/001/NO-003/NO

Neupopeg

Norway

27.8.2007

EU/1/02/228/001-003

Neupopeg

Liechtenstein

31.8.2007

EU/1/02/229/001/NO-037/NO

Actraphane

Norway

9.10.2007

EU/1/02/229/001-037

Actraphane

Liechtenstein

31.10.2007

EU/1/02/229/001-037/IS

Actraphane

Iceland

15.10.2007

EU/1/02/230/001/NO-017/NO

Actrapid

Norway

9.10.2007

EU/1/02/230/001-017

Actrapid

Liechtenstein

31.10.2007

EU/1/02/230/001-017/IS

Actrapid

Iceland

15.10.2007

EU/1/02/231/001/NO-037/NO

Mixtard

Norway

9.10.2007

EU/1/02/231/001-037

Mixtard

Liechtenstein

31.10.2007

EU/1/02/231/001-037/IS

Mixtard

Iceland

16.10.2007

EU/1/02/232/001/NO-003/NO

Velosulin

Norway

9.10.2007

EU/1/02/232/001-003

Velosulin

Liechtenstein

31.10.2007

EU/1/02/232/001-003/IS

Velosulin

Iceland

15.10.2007

EU/1/02/233/001/NO-017/NO

Insulatard

Norway

9.10.2007

EU/1/02/233/001-017

Insulatard

Liechtenstein

31.10.2007

EU/1/02/233/001-017/IS

Insulatard

Iceland

16.10.2007

EU/1/02/234/001/NO-017/NO

Protaphane

Norway

9.10.2007

EU/1/02/234/001-017

Protaphane

Liechtenstein

31.10.2007

EU/1/02/234/001-017/IS

Protaphane

Iceland

15.10.2007

EU/1/02/237/001/NO-008/NO

Cialis

Norway

15.10.2007

EU/1/02/237/001-008

Cialis

Liechtenstein

31.10.2007

EU/1/02/237/001-008/IS

Cialis

Iceland

15.10.2007

EU/1/02/238/001

Zavesca

Liechtenstein

31.10.2007

EU/1/02/238/001/IS

Zavesca

Iceland

1.10.2007

EU/1/02/238/001/NO

Zavesca

Norway

17.9.2007

EU/1/02/240/001/NO-004/NO

Somavert

Norway

26.9.2007

EU/1/02/240/001-004

Somavert

Liechtenstein

31.10.2007

EU/1/02/240/001-004/IS

Somavert

Iceland

19.10.2007

EU/1/97/031/001/NO-003/NO, 019/NO-046/NO

Neorecormon

Norway

17.7.2007

EU/1/97/031/001-003, 019-046

NeoRecormon

Liechtenstein

31.8.2007

EU/1/97/031/001-013, 019-024, 027-046/IS

NeoRecormon

Iceland

11.7.2007

EU/1/97/032/001/NO

LeukoScan

Norway

4.7.2007

EU/1/97/037/001/IS

Vistide

Iceland

6.7.2007

EU/1/97/037/001/NO

Vistide

Norway

13.9.2007

EU/1/97/039/001/NO-004/NO

Cystagon

Norway

31.7.2007

EU/1/97/039/001-004

Cystagon

Liechtenstein

31.8.2007

EU/1/97/039/001-004/IS

Cystagon

Iceland

11.7.2007

EU/1/97/040/001/NO-002/NO

Teslascan

Norway

20.8.2007

EU/1/97/043/001/NO-003/NO

Revasc

Norway

16.7.2007

EU/1/97/043/001-003

Revasc

Liechtenstein

31.8.2007

EU/1/97/043/001-003/IS

Revasc

Iceland

11.7.2007

EU/1/97/046/001/NO-039/NO

Aprovel

Norway

19.9.2007

EU/1/97/046/001-033

Aprovel

Liechtenstein

31.10.2007

EU/1/97/046/001-039/IS

Aprovel

Iceland

18.9.2007

EU/1/97/047/001/NO-007/NO

BeneFIX

Norway

11.9.2007

EU/1/97/047/001-007

Benefix

Liechtenstein

31.10.2007

EU/1/97/047/001-007/IS

BeneFix

Iceland

31.8.2007

EU/1/97/049/001/NO-039/NO

Karvea

Norway

20.9.2007

EU/1/97/049/001-033

Karvea

Liechtenstein

31.10.2007

EU/1/97/049/001-039/IS

Karvea

Iceland

17.9.2007

EU/1/97/050/001/NO-006/NO, 009/NO-012/NO

Sifrol

Norway

16.10.2007

EU/1/97/050/001-006, 009-012

Sifrol

Liechtenstein

31.10.2007

EU/1/97/050/001-006, 009-012/IS

Sifrol

Iceland

15.10.2007

EU/1/97/051/001/NO-006/NO, 009/NO-012/NO

Mirapexin

Norway

15.10.2007

EU/1/97/051/001-006, 009-012

Mirapexin

Liechtenstein

31.10.2007

EU/1/97/051/001-006, 009-012/IS

Mirapexin

Iceland

15.10.2007

EU/1/97/053/001/NO-005/NO

Cerezyme

Norway

9.10.2007

EU/1/97/053/001-005

Cerezyme

Liechtenstein

31.10.2007

EU/1/97/053/001-005/IS

Cerezyme

Iceland

15.10.2007

EU/1/97/057/001

Quadramet

Liechtenstein

31.12.2007

EU/2/02/032/001/IS

Vaxxitek HVT + IBD

Iceland

10.7.2007

EU/2/02/033/001/IS

Dexdomitor

Iceland

17.8.2007

EU/2/02/034/001/IS

Nobivac Bb cat

Iceland

19.10.2007

EU/2/02/035/001-007

SevoFlo

Liechtenstein

31.12.2007

EU/2/02/035/001-007/IS

SevoFlo

Iceland

6.12.2007

EU/2/033/001

Dexdomitor

Liechtenstein

31.10.2007

EU/2/034/001

Nobivac Bb

Liechtenstein

31.10.2007

EU/2/97/001-009/IS

Quadrisol

Iceland

10.12.2007

EU/2/97/004/001, EU/2/97/004/003-028

Metacam

Liechtenstein

31.12.2007

EU/2/97/004/001/NO, 003/NO-030/NO

Metacam

Norway

17.12.2007

EU/2/97/005/001-009

Quadrisol

Liechtenstein

31.12.2007

EU/2/98/010/004-014, 017-018, 021-024/IS

Econor

Iceland

8.11.2007

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2007:

| EU Number | Product | Country | Date of extention |
| --- | --- | --- | --- |
| EU/1/00/151/023-024 | Glustin | Liechtenstein | 31.10.2007 |
| EU/1/01/197/003/NO-005/NO | Foscan | Norway | 8.11.2007 |
| EU/1/01/197/003-005 | Foscan | Liechtenstein | 31.10.2007 |
| EU/1/01/197/003-005/IS | Foscan | Iceland | 12.11.2007 |
| EU/1/02/222/003/NO-004/NO | Tamiflu | Norway | 27.9.2007 |
| EU/1/02/222/003-004 | Tamiflu | Liechtenstein | 31.10.2007 |
| EU/1/02/222/003-004/IS | Tamiflu | Iceland | 15.10.2007 |
| EU/1/02/237/006/NO-008/NO | Cialis | Norway | 3.7.2007 |
| EU/1/02/237/006-008 | Cialis | Liechtenstein | 31.8.2007 |
| EU/1/03/254/002 | Busilvex | Liechtenstein | 31.12.2007 |
| EU/1/03/260/016-018 | Stalevo | Liechtenstein | 31.10.2007 |
| EU/1/04/290/002 | Alimta | Liechtenstein | 31.12.2007 |
| EU/1/04/290/002/IS | Alimta | Iceland | 15.11.2007 |
| EU/1/04/296/009 | Cymbalta | Liechtenstein | 31.10.2007 |
| EU/1/05/310/006/NO-009/NO | Fosavance | Norway | 8.11.2007 |
| EU/1/05/310/006-009 | Fosavance | Liechtenstein | 31.12.2007 |
| EU/1/05/310/006-009/IS | Fosavance | Iceland | 19.10.2007 |
| EU/1/05/325/002 | Macugen | Liechtenstein | 31.12.2007 |
| EU/1/06/332/004/NO-006/NO | Omnitrope | Norway | 10.9.2007 |
| EU/1/06/332/007/NO-009/NO | Omnitrope | Norway | 8.11.2007 |
| EU/1/06/332/007-009 | Omnitrope | Liechtenstein | 31.10.2007 |
| EU/1/06/332/007-009/IS | Omnitrope | Iceland | 17.10.2007 |
| EU/1/06/344/010-011 | Acomplia | Liechtenstein | 31.10.2007 |
| EU/1/06/345/010-011 | Zimulti | Liechtenstein | 31.10.2007 |
| EU/1/06/347/004-006 | Sutent | Liechtenstein | 31.12.2007 |
| EU/1/06/361/002 | Luminity | Liechtenstein | 31.12.2007 |
| EU/1/06/364/006/NO-009/NO | Adrovance | Norway | 14.11.2007 |
| EU/1/06/364/006-009 | Adrovance | Liechtenstein | 31.10.2007 |
| EU/1/06/364/006-009/IS | Adrovance | Iceland | 19.10.2007 |
| EU/1/06/366/005-016 | Tandemact | Liechtenstein | 31.12.2007 |
| EU/1/95/003/005-006 | Betaferon | Liechtenstein | 31.10.2007 |
| EU/1/96/022/023-034 | Zyprexa | Liechtenstein | 31.8.2007 |
| EU/1/97/033/004 | Avonex | Liechtenstein | 31.8.2007 |
| EU/1/97/046/034-039 | Aprovel | Liechtenstein | 31.10.2007 |
| EU/1/97/047/004/NO-007/NO | BeneFIX | Norway | 4.9.2007 |
| EU/1/97/047/004-007 | BenFix | Liechtenstein | 31.8.2007 |
| EU/1/97/047/007/IS | Benefix | Iceland | 31.8.2007 |
| EU/1/97/049/034-039 | Karvea | Liechtenstein | 31.10.2007 |
| EU/1/98/066/019/NO-026/NO | Exelon | Norway | 10.10.2007 |
| EU/1/98/066/019-026 | Exelon | Liechtenstein | 31.10.2007 |
| EU/1/98/066/019-026/IS | Exelon | Iceland | 17.10.2007 |
| EU/1/98/069/007a, 007b | Plavix | Liechtenstein | 31.8.2007 |
| EU/1/98/070/007a, 007b | Iscover | Liechtenstein | 31.8.2007 |
| EU/1/98/085/029-034 | Karvezide | Liechtenstein | 31.10.2007 |
| EU/1/98/086/029-034 | CoAprovel | Liechtenstein | 31.10.2007 |
| EU/1/98/092/019/NO-026/NO | Prometax | Norway | 10.10.2007 |
| EU/1/98/092/019-026 | Prometax | Liechtenstein | 31.10.2007 |
| EU/1/98/092/019-026/IS | Prometax | Iceland | 18.10.2007 |
| EU/1/99/108/002-003 | Ferriprox | Liechtenstein | 31.12.2007 |
| EU/1/99/108/002/NO-003/NO | Ferriprox | Norway | 5.12.2007 |
| EU/1/99/108/002-003/IS | Ferriprox | Iceland | 10.12.2007 |
| EU/2/039/019-030 | Advocate | Liechtenstein | 31.8.2007 |
| EU/2/97/004/029-030 | Metacam | Liechtenstein | 31.12.2007 |

EU Number

Product

Country

Date of extention

EU/1/00/151/023-024

Glustin

Liechtenstein

31.10.2007

EU/1/01/197/003/NO-005/NO

Foscan

Norway

8.11.2007

EU/1/01/197/003-005

Foscan

Liechtenstein

31.10.2007

EU/1/01/197/003-005/IS

Foscan

Iceland

12.11.2007

EU/1/02/222/003/NO-004/NO

Tamiflu

Norway

27.9.2007

EU/1/02/222/003-004

Tamiflu

Liechtenstein

31.10.2007

EU/1/02/222/003-004/IS

Tamiflu

Iceland

15.10.2007

EU/1/02/237/006/NO-008/NO

Cialis

Norway

3.7.2007

EU/1/02/237/006-008

Cialis

Liechtenstein

31.8.2007

EU/1/03/254/002

Busilvex

Liechtenstein

31.12.2007

EU/1/03/260/016-018

Stalevo

Liechtenstein

31.10.2007

EU/1/04/290/002

Alimta

Liechtenstein

31.12.2007

EU/1/04/290/002/IS

Alimta

Iceland

15.11.2007

EU/1/04/296/009

Cymbalta

Liechtenstein

31.10.2007

EU/1/05/310/006/NO-009/NO

Fosavance

Norway

8.11.2007

EU/1/05/310/006-009

Fosavance

Liechtenstein

31.12.2007

EU/1/05/310/006-009/IS

Fosavance

Iceland

19.10.2007

EU/1/05/325/002

Macugen

Liechtenstein

31.12.2007

EU/1/06/332/004/NO-006/NO

Omnitrope

Norway

10.9.2007

EU/1/06/332/007/NO-009/NO

Omnitrope

Norway

8.11.2007

EU/1/06/332/007-009

Omnitrope

Liechtenstein

31.10.2007

EU/1/06/332/007-009/IS

Omnitrope

Iceland

17.10.2007

EU/1/06/344/010-011

Acomplia

Liechtenstein

31.10.2007

EU/1/06/345/010-011

Zimulti

Liechtenstein

31.10.2007

EU/1/06/347/004-006

Sutent

Liechtenstein

31.12.2007

EU/1/06/361/002

Luminity

Liechtenstein

31.12.2007

EU/1/06/364/006/NO-009/NO

Adrovance

Norway

14.11.2007

EU/1/06/364/006-009

Adrovance

Liechtenstein

31.10.2007

EU/1/06/364/006-009/IS

Adrovance

Iceland

19.10.2007

EU/1/06/366/005-016

Tandemact

Liechtenstein

31.12.2007

EU/1/95/003/005-006

Betaferon

Liechtenstein

31.10.2007

EU/1/96/022/023-034

Zyprexa

Liechtenstein

31.8.2007

EU/1/97/033/004

Avonex

Liechtenstein

31.8.2007

EU/1/97/046/034-039

Aprovel

Liechtenstein

31.10.2007

EU/1/97/047/004/NO-007/NO

BeneFIX

Norway

4.9.2007

EU/1/97/047/004-007

BenFix

Liechtenstein

31.8.2007

EU/1/97/047/007/IS

Benefix

Iceland

31.8.2007

EU/1/97/049/034-039

Karvea

Liechtenstein

31.10.2007

EU/1/98/066/019/NO-026/NO

Exelon

Norway

10.10.2007

EU/1/98/066/019-026

Exelon

Liechtenstein

31.10.2007

EU/1/98/066/019-026/IS

Exelon

Iceland

17.10.2007

EU/1/98/069/007a, 007b

Plavix

Liechtenstein

31.8.2007

EU/1/98/070/007a, 007b

Iscover

Liechtenstein

31.8.2007

EU/1/98/085/029-034

Karvezide

Liechtenstein

31.10.2007

EU/1/98/086/029-034

CoAprovel

Liechtenstein

31.10.2007

EU/1/98/092/019/NO-026/NO

Prometax

Norway

10.10.2007

EU/1/98/092/019-026

Prometax

Liechtenstein

31.10.2007

EU/1/98/092/019-026/IS

Prometax

Iceland

18.10.2007

EU/1/99/108/002-003

Ferriprox

Liechtenstein

31.12.2007

EU/1/99/108/002/NO-003/NO

Ferriprox

Norway

5.12.2007

EU/1/99/108/002-003/IS

Ferriprox

Iceland

10.12.2007

EU/2/039/019-030

Advocate

Liechtenstein

31.8.2007

EU/2/97/004/029-030

Metacam

Liechtenstein

31.12.2007

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2007:

| EU Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/01/92/001-005 | Levviax | Liechtenstein | 31.12.2007 |
| EU/1/03/257/001/NO-010/NO | Trudexa | Norway | 29.8.2007 |
| EU/1/03/257/001-010 | Trudexa | Liechtenstein | 31.8.2007 |
| EU/1/03/257/001-010/IS | Trudexa | Iceland | 9.8.2007 |

EU Number

Product

Country

Date of withdrawal

EU/1/01/92/001-005

Levviax

Liechtenstein

31.12.2007

EU/1/03/257/001/NO-010/NO

Trudexa

Norway

29.8.2007

EU/1/03/257/001-010

Trudexa

Liechtenstein

31.8.2007

EU/1/03/257/001-010/IS

Trudexa

Iceland

9.8.2007

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2007:

| EU Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/97/054/001, 003-005 | Viracept | Liechtenstein | 31.8.2007 (1) |
| EU/1/97/054/001-005/IS | Viracept | Iceland | 7.8.2007 (2) |
| EU/1/97/054/001/NO, 003/NO-005/NO | Viracept | Norway | 27.8.2007 (3) |

EU Number

Product

Country

Date of suspension

EU/1/97/054/001, 003-005

Viracept

Liechtenstein

31.8.2007 (1)

EU/1/97/054/001-005/IS

Viracept

Iceland

7.8.2007 (2)

EU/1/97/054/001/NO, 003/NO-005/NO

Viracept

Norway

27.8.2007 (3)

---

(1)  Lifting of the suspension 31 October 2007 — Viracept EU/1/97/054/001, 003-005.

(2)  Lifting of the suspension 14 November 2007 — Viracept EU/1/97/054/001, 004-005/IS.

(3)  Lifting of the suspension 29 October 2007 — Viracept EU/1/97/054/001/NO, 003/NO-005/NO.

---